clozapine-N-oxide drug
Evidence from:
primary |
all sources
Related entities (11)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| clozapine | associated_with | clozapine-N-oxide | — | 1 |
| clozapine-N-oxide | associated_with | GABA | 0.001 | 1 |
| clozapine-N-oxide | regulates | GABA | — | 1 |
| clozapine-N-oxide | regulates | GCaMP6f | — | 1 |
| clozapine-N-oxide | associated_with | glutamatergic neurons | 0.001 | 1 |
| clozapine-N-oxide | targets | hM3Dq | — | 1 |
| clozapine-N-oxide | interacts_with | hM3Dq | — | 1 |
| clozapine-N-oxide | regulates | network activity | — | 1 |
| clozapine-N-oxide | regulates | neuronal activity | — | 1 |
| HEPES buffer | associated_with | clozapine-N-oxide | — | 1 |
| hM3Dq | interacts_with | clozapine-N-oxide | — | 1 |
Mentioned in (5)
Papers in which this entity is mentioned.
- Activation of the anterior cingulate cortex ameliorates anxiety in a preclinical model of fetal alcohol spectrum disorders. (2022)
- Development of a high-throughput arrayed neural circuitry platform using human induced neurons for drug screening applications. (2020)
- Mental Illnesses-Associated Fxr1 and Its Negative Regulator Gsk3β Are Modulators of Anxiety and Glutamatergic Neurotransmission. (2018)
- Branch-specific dendritic Ca(2+) spikes cause persistent synaptic plasticity. (2015)
- Cholinergic modulation of synaptic integration and dendritic excitability in the striatum. (2011)
Merged raw entities (2)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| cno | drug | 4 | 20 |
| clozapine-n-oxide | drug | 3 | 6 |